Earningsreport

Q2/2021 6/30/2021 EPS -0.350 ZacksConsensus -0.420 ActVsEst 0.070 - Beat

AB Corporate Bond ETF  (EYEG) 
NASDAQ:AMEX Investor Relations: eyegatepharma.com/investors